Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature
This review (2022) explores the role and value of the setting in the psychedelic experience and the subsequent therapeutic outcomes. It was found that while the importance of setting is emphasized in the literature, there is yet to be any consistent and rigorous testing of setting and its complexities. There is yet to be a shared consensus on the effects setting has and the mechanism by which it affects outcomes as a result.
Authors
- Frederick Barrett
Published
Abstract
The health and well-being impacts of art and aesthetic experiences have been rigorously studied by a range of disciplines, including cognitive neuroscience, psychiatry, public health, and translational clinical research. These experiences, encompassed in the concepts of set and setting, have long been claimed to be pivotal in determining the acute and enduring effects of psychedelic experiences. Responding to the field’s longstanding emphasis on the role and value of the setting, a rapid scoping review was undertaken to identify the extent to which effects of setting and aesthetics on psychedelic experiences and therapies have been explicitly studied. It offers an analysis of the strengths and limitations of the extant literature and discusses evidentiary gaps as well as evidentiary opportunities for the field. The 43 included studies indicate apparent consensus regarding the importance of setting in psychedelic therapies, as well as consistent interest in theorizing about these effects. However, this consensus has yet to generate consistent, prospective, rigorous tests of setting and its complexities. As a result, the field continues to lack understanding or agreement regarding the effects of various specific elements of setting, the mechanisms by which they affect outcomes, for whom these effects occur, under what circumstances, given what conditions, and other critical factors. Further studies of setting and aesthetics in the context of psychedelic therapies are likely to not only improve these therapies and their delivery but also inform considerations of setting and aesthetics for non-psychedelic interventions.
Research Summary of 'Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature'
Introduction
Setting, aesthetics, and the arts have long been implicated in human health and well-being, with historical and contemporary work across disciplines documenting effects of visual art, music, and built environments on emotions, social connectedness, and clinical outcomes. Golden and colleagues situate their review within this broader literature and note that the familiar psychedelic research maxim “set and setting” captures the idea that both mindset (set) and environmental context (setting) shape acute and enduring effects of classic psychedelics. Despite frequent citation of setting in clinical guidance and practice, the authors argue that it remains unclear how extensively specific elements of setting and aesthetics have been empirically tested, and which components meaningfully affect outcomes. This paper reports a rapid scoping review intended to map published research that explicitly examines effects of setting and aesthetics on psychedelic experiences and therapies. The review asks which setting elements have been studied and with which drugs, how setting has been studied (study designs and measures), what initial findings exist, and where evidentiary gaps and concentrations remain. The stated aim is to consolidate existing knowledge, highlight limitations in the evidence base, and identify opportunities to guide further empirical work that could improve delivery of psychedelic therapies.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typemeta
- Journal
- Topics
- Author
- APA Citation
Golden, T. L., Magsamen, S., Sandu, C. C., Lin, S., Roebuck, G. M., Shi, K. M., & Barrett, F. S. (2022). Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature. Current Topics in Behavioral Neurosciences, 35-70. https://doi.org/10.1007/7854_2021_298
References (21)
Papers cited by this study that are also in Blossom
Slevc, L. R., Barrett, F. S., Robbins, H. et al. · Frontiers in Psychology (2017)
Belser, A. B., Agin-Liebes, G. I., Swift, T. C. et al. · Journal of Humanistic Psychology (2017)
Bøhling, F. · International Journal of Drug Policy (2017)
Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S. et al. · Journal of Psychopharmacology (2016)
Richards, W. A., Garcia-Romeu, A. · International Review of Psychiatry (2018)
Haijen, E. C. H. M., Kaelen, M., Roseman, L. et al. · Frontiers in Pharmacology (2018)
Hartogsohn, I. · Drug Science Policy and Law (2017)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Kaelen, M., Giribaldi, B., Raine, J. et al. · Psychopharmacology (2018)
Kaelen, M., Roseman, L., Kahan, J. et al. · European Neuropsychopharmacology (2016)
Show all 21 referencesShow fewer
Kettner, H., Rosas, F. E., Timmermann, C. et al. · Frontiers in Pharmacology (2021)
Leary, T., Litwin, G. H., Metzner, R. · Journal of Nervous and Mental Disease (1977)
Olson, J. A., Suissa-Rocheleau, L., Lifshitz, M. et al. · Psychopharmacology (2020)
Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)
Perkins, D., Schubert, V., Simonová, H. et al. · Frontiers in Pharmacology (2021)
Phelps, J. · Journal of Humanistic Psychology (2017)
Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)
Roseman, L., Ron, Y., Saca, A. et al. · Frontiers in Pharmacology (2021)
Smigielski, L., Kometer, M., Scheidegger, M. et al. · Scientific Reports (2019)
Strickland, J. C., Garcia-Romeu, A., Johnson, M. W. · ACS Pharmacology and Translational Science (2020)
Uthaug, M. V., Mason, N. L., Toennes, S. W. et al. · Psychopharmacology (2021)
Cited By (13)
Papers in Blossom that reference this study
Tylš, F., Páleníček, T., Klučková, T. et al. · Pharmacological Reports (2025)
Pronovost-Morgan, C., Greenway, K. T., Roseman, L. · Nature Medicine (2025)
McAlpine, R., Kamboj, S. K. · Scientific Reports (2024)
Calder, A. E., Rausch, B., Liechti, M. E. et al. · Journal of Psychopharmacology (2024)
Aday, J. S., Horton, D. M., Fernandes-Osterhold, G. et al. · Psychopharmacology (2024)
Black, J. C., Monte, A. A., Dasgupta, N. et al. · Nature Mental Health (2024)
Sjöström, D. K., Claesdotter-Knutsson, E., Kajonius, P. J. · Scientific Reports (2024)
Borkel, L. F., Rojas-Hernández, J., Henríquez-Hernández, L. A. et al. · Expert Review of Clinical Pharmacology (2023)
Orłowski, P., Hobot, J., Ruban, A. et al. · Journal of Psychopharmacology (2023)
Zeifman, R. J., Wagner, A. C., Monson, C. M. et al. · Journal of Affective Disorders (2023)
Show all 13 papersShow fewer
Heifets, B. D., Olson, D. E. · Neuropsychopharmacology (2023)
Pronovost-Morgan, C., Hartogsohn, I., Ramaekers, J. G. · Journal of Psychopharmacology (2023)
Lake, S., Lucas, P. · Psychedelic Medicine (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.